China’s Parents Crave Illegally Imported Baby Formula

China’s Parents Crave Illegally Imported Baby Formula

By Liza Lin and Julie Cruz on May 02, 2013

comp_babyformula19__01__630x420

For Hong Kong customs agents, baby formula is the new heroin. On March 1 a law went into effect limiting the amount of powdered milk travelers can carry out of Hong Kong to two 2-pound cans each. Since then, more people have been arrested for smuggling baby formula than were caught all of last year with heroin and cocaine. As of April 23, border officials say they’d seized nearly 20,000 pounds of powdered milk and arrested 879 people, many of whom were part of a smuggling syndicate. In 2012, 420-plus people were arrested for smuggling illegal drugs through Hong Kong.

Many Chinese parents are desperate to get their hands on foreign-made baby formula after numerous food safety scandals in recent years. In 2008 at least 22 Chinese companies were found to have sold dairy products containing melamine, a toxic chemical that can make diluted milk appear to have a higher protein content. Six babies died as a result. In 2011, China’s largest milk producer, China Mengniu Dairy (2319), said in a statement that moldy cattle feed led to excessive toxin levels in its milk. Last year another large milk producer, Inner Mongolia Yili Industrial Group (600887), recalled formula tainted with mercury. “Chinese consumers are so frightened and so sensitive to safety issues with milk powder that they are willing to pay a higher premium than consumers anywhere else,” says James Roy, a Shanghai-based senior analyst at China Market Research Group. That willingness to pay has led to baby formula shortages in Hong Kong, where food safety standards are higher. The surge in Chinese demand has even hit foreign markets, where baby formula is often cheaper than in China. Over the past year, stores in Germany, the U.K., and New Zealand have put limits on all bulk purchases of formula, such as Danone’s (BN)Aptamil and Mead Johnson Nutrition’s (MJN) Enfamil.With a limited supply available on Chinese e-commerce sites, consumers’ next best choice is to buy those foreign brands domestically. This gives international baby products companies a golden opportunity to boost their share of China’s formula market at the expense of local rivals. Baby formula sales grew 29 percent last year, to 95.2 billion yuan ($15.4 billion), more than four times the size of the U.S. market, according to industry analyst Mintel Group. This year, China’s top five international sellers of formula—Danone, Nestlé (NESN), Mead Johnson, Abbott Laboratories (ABT), andWyeth (PFE)—will increase their total market share by 5 percentage points, to about 55 percent, China Market Research estimates.

Danone reported first-quarter sales growth that beat estimates as China safety worries helped drive a 17 percent jump in its baby food revenue. Nestlé reported that its first-quarter infant nutrition sales increased 10 percent, outpacing the company’s overall growth. Illinois-based Mead Johnson, which counts on China for 30 percent of its total sales, saw operating profit rise 12 percent, to $870 million, last year on revenue that grew 6.1 percent. Meanwhile, profits at Mengniu shrank 16 percent last year, to 1.45 billion yuan, as sales fell 3.5 percent. Food quality and safety incidents affected consumer confidence and sales, it said in a March 27 statement.

As foreign companies ramp up production in China, they’ll have to convince Chinese consumers that their formula is safe. While Danone says it buys the milk it uses in China from New Zealand, Nestlé uses a combination of local and imported milk and says it’s working to teach local Chinese dairy farmers better safety practices. Heiko Schipper, managing director of Nestlé’s Greater China food and beverage division, says she can understand why Chinese parents are so wary of local milk. “When you talk about the health of your baby, it’s very hard to say to people, ‘You are overreacting.’ ”

The bottom line: Local food scares have provided an opportunity for foreign companies to increase their share of China’s $15 billion market for baby formula.

Unknown's avatarAbout bambooinnovator
Kee Koon Boon (“KB”) is the co-founder and director of HERO Investment Management which provides specialized fund management and investment advisory services to the ARCHEA Asia HERO Innovators Fund (www.heroinnovator.com), the only Asian SMID-cap tech-focused fund in the industry. KB is an internationally featured investor rooted in the principles of value investing for over a decade as a fund manager and analyst in the Asian capital markets who started his career at a boutique hedge fund in Singapore where he was with the firm since 2002 and was also part of the core investment committee in significantly outperforming the index in the 10-year-plus-old flagship Asian fund. He was also the portfolio manager for Asia-Pacific equities at Korea’s largest mutual fund company. Prior to setting up the H.E.R.O. Innovators Fund, KB was the Chief Investment Officer & CEO of a Singapore Registered Fund Management Company (RFMC) where he is responsible for listed Asian equity investments. KB had taught accounting at the Singapore Management University (SMU) as a faculty member and also pioneered the 15-week course on Accounting Fraud in Asia as an official module at SMU. KB remains grateful and honored to be invited by Singapore’s financial regulator Monetary Authority of Singapore (MAS) to present to their top management team about implementing a world’s first fact-based forward-looking fraud detection framework to bring about benefits for the capital markets in Singapore and for the public and investment community. KB also served the community in sharing his insights in writing articles about value investing and corporate governance in the media that include Business Times, Straits Times, Jakarta Post, Manual of Ideas, Investopedia, TedXWallStreet. He had also presented in top investment, banking and finance conferences in America, Italy, Sydney, Cape Town, HK, China. He has trained CEOs, entrepreneurs, CFOs, management executives in business strategy & business model innovation in Singapore, HK and China.

Leave a comment